Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SR-T100 Gel for Actinic Keratosis and Bowen's Disease
NCT02085395Phase 2Completed
- Sponsor
- G&E Herbal Biotechnology
- Start
- Nov 2007
- Primary completion
- Apr 2010
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SR-T100 in actinic keratosis (AK), squamous cell carcinoma in situ (SCCIS), sponsored by G&E Herbal Biotechnology. Started Nov 2007; status: completed.
02
Drugs
SR-T100
03
Conditions
actinic keratosis (AK)squamous cell carcinoma in situ (SCCIS)
Beyond the preview
Go deeper on NCT02085395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02085395.